hcareincorp

1
Plot - 286, Industrial Area Phase-1, Panchkula
(HARYANA) For Query  91 92162 95095 Email us
hcareindia_at_gmail.com Website https//www.hcarein
dia.com/
2

• INDIAN PHARMACEUTICAL INDUSTRY
• Indian Pharmaceutical industry is the world's
  third-largest in terms of volume
• India is now among the top five pharmaceutical
  emerging markets of the world
• Indian pharmaceutical industry has become the
  third largest producer in the world and is poised
  to grow into an industry of 20 billion in 2015
  from the current turnover of 12 billion
• Indian Government through NPPA play a leading
  role in the global market and to ensure abundant
  availability, at reasonable prices within the
  country, of good quality pharmaceuticals of mass
  consumption.
• According to Brand India Equity Foundation, the
  Indian pharmaceutical market is
• likely to grow at a compound annual growth rate
  of 18-20 per cent in between 2017-20
• Rapid urbanization will lead to 250 million
  people moving from rural areas to Urban centre's
  during next two decades, the share of pharma
  growth would expected to increase by 8 by
  2023.

3
ABOUT OUR COMPANY
H CARE INCORP started in the year 2009 with the
young and dynamic professional having experience
of 22nd years in the field of Pharmaceutical
Research Development. We are Suppliers of
Pharmaceutical Dosage forms like Tablets,
Capsules, Syrup Dry Syrups, Suspensions,
Injections Powder. Ours presence has expanded
almost all states of India and also applied for
Export license to enter globally. Companys
Annual 2021-22 Turn Over is expected to be more
than 30 Crores.
4
(No Transcript)
5
MANAGEMENT
Mr. MUNISH GOYAL is an Independent Director of
our Company. He is a Post graduate in Pharmacy
(M.Pharma) from Rajiv Gandhi University of Health
sciences, Bangalore and also done MBA from
Symbiosis University, Pune. Industrial
Experience Mr. Munish Goyal has significant
experience in the pharmaceutical industry. He had
held several senior management positions
including the position of the Senior Research
Scientist of Dabur Research Foundation, Ghaziabad
and Group leader of Torrent Research Centre,
Ahmedabad. He had the part of Research team of
Ind-Swift Ltd, Panchkula and also got experience
of Quality assurance in Paksons Pharmaceuticals,
New Delhi. During his Pharma industry tenure, he
has worked on Research and Development of new
formulations. His vast experience of Research and
Development plays a key role in the success of
establishment of H Care Incorp. And further
expansion with new divisions.
6
DIVISIONS BRANCHES

1. MEDIQUEST INC
2. INMED THERAPEUTICS INDIA
3. MEDONS INDIA
4. NUTICA HERBOCARE (HERBAL)
5. FEMISTA PHARMA (GYNEAC)

7

• MISSION VISION
• Mission
• To provide Innovative Products through
  persistent R D
• To become a leading pharmaceutical company
  known for availability of all new moieties by
  constantly introducing  advanced product range
• To become a preferred employer in the pharma
  sector
• Vision
• To be an organization focused on the future,
  recognized for challenging healthcare barriers
  globally.
• To excel in manufacturing the highest quality
  pharmaceutical products with ethical standards
  and obligations to do things right and fair.

8

• QUALITY ASSURANCE
• In order to maintain strict quality standards,
  Company have developed a stringent quality
  procedure that is rigorously followed at each
  step of entire process.
• Maintained a high-end quality-testing unit that
  is integrated with numerous testing instruments
• In the formulation, we use quality-tested
  ingredients that are sourced from the reliable
  and genuine vendors of the industry
• Further, the prepared drugs also go through
  several testing procedures, in order to know
  their side effects and efficacy
• Manufactured from well reputed WHO, ISO-GMP
  approved units like The on Pharmaceuticals,
  Perennial Pharma, SciTech biotech, Ultratech
  Pharmaceuticals, Life vision Pharma etc.

9
PRODUCT RANGE

• HCARE INCORP. Has more than 240 Products in all
  dosage forms like
• TABLETS
• CAPSULES SOFTGEL CAPSULE
• INJECTABLES I.V. FLUIDS
• POWDERS SACHETS
• which covers all the Gernal segments of
  Pharmaceuticals Therapeutic Index like
• ANTIBIOTICS ANTIINFECTIVES
• GASTROINTESTINAL TRACT
• MUSCULO SKELETAL DISORDERS NSAIDS
• ALLERGIC DISORDERS
• RESPIRATORY SYSTEM (ANTI COUGH COLD)
• GENITO URINARY SYSTEM
• NUTRITION MULTIVITAMINS
• HEPATOPROTECTIVE
• PEADIATRIC
• GYNEAC

10
COMPANY STRENGTH
BEST INFRA-STRUCTURE
QUALIFIED STAFF
NEW LATEST DCGI MOLECULES
HCARE INCORP
BEST SERVICES
FRANCHISEE SUPPORT
QUALITY PRODUCTS
11
NEW DCGI MOLECULES

1. CEFIXIME 200MG OFLOXACIN 200MG TABLETS
2. CEFIXIME 200MG AZITHROMYCIN 250MG
   LACTOBACILLUS TABLETS
3. CCM CALCITRIOL VITAMIN K2-7 ZINC SOFTGEL
   CAPSULE
4. DICLOFENAC SODIUM 50MG RABEPRAZOLE 20MG TABLET
5. CHOLECALCIFEROL 1,60,000 I.U. CHEWABLE TABLET
6. TRYPSIN CHYMOTRYPSIN 50,000 I.U. ACECLOFENAC
   100MG TABLET
7. MEBEVARINE 200MG SR TABLET
8. MEBEVERINE 135MG CHLODIAZAPOXIDE 75MG TABLET
9. RABEPRAZOLE 20MG LEVOSULPRIDE 75MG SR CAPSULE
10. EDARAVONE 1.5MG/ML INJECTION
11. BIOACTIVE COLLEGEN PEPTIDE SACHET
12. ESOMEPRAZOLE 30MG DOMPERIDONE 40MG SR CAPSULE
13. TAMSOLUSIN 0.4MG DUTASTERIDE 0.5MG MR TABLET

12
PRODUCT PACKINGS--ANTIBIOTICS
13
(No Transcript)
14
ANALGESICS /ANTI-INFLAMATORY/ NSAIDS
15
(No Transcript)
16
HEPATO PROTECTIVE
17
GASTRIC RANGE
18
GYNAEC RANGE
19
(No Transcript)
20
PADEATRIC RANGE
21
ANTI COUGH COLD/ ANTI HISTAMINIC
22
SYRUPS
23
ORTHO PRODUCTS
24
(No Transcript)
25
INJECTABLES
26
(No Transcript)
27
Managing 500 Associates
1000 Products and 4 Speciality Divisions
Winner of the Quality PCD Company Award
Serving more than 80000 Health Professionals
OUR PRESENCE
28
THANK YOU